- Home
- SRL vs HLVX Comparison
SRL vs HLVX Comparison
Compare SRL & HLVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SRL
- HLVX
- Stock Information
- Founded
- SRL 2017
- HLVX 2020
- Country
- SRL China
- HLVX United States
- Employees
- SRL N/A
- HLVX N/A
- Industry
- SRL Professional Services
- HLVX Biotechnology: Pharmaceutical Preparations
- Sector
- SRL Consumer Discretionary
- HLVX Health Care
- Exchange
- SRL Nasdaq
- HLVX Nasdaq
- Market Cap
- SRL 89.5M
- HLVX 83.7M
- IPO Year
- SRL N/A
- HLVX 2022
- Fundamental
- Price
- SRL $5.98
- HLVX $2.09
- Analyst Decision
- SRL
- HLVX Hold
- Analyst Count
- SRL 0
- HLVX 5
- Target Price
- SRL N/A
- HLVX $2.33
- AVG Volume (30 Days)
- SRL 5.0K
- HLVX 430.4K
- Earning Date
- SRL 07-22-2025
- HLVX 08-07-2025
- Dividend Yield
- SRL 17.13%
- HLVX N/A
- EPS Growth
- SRL N/A
- HLVX N/A
- EPS
- SRL N/A
- HLVX N/A
- Revenue
- SRL $24,535,042.00
- HLVX N/A
- Revenue This Year
- SRL N/A
- HLVX N/A
- Revenue Next Year
- SRL N/A
- HLVX N/A
- P/E Ratio
- SRL N/A
- HLVX N/A
- Revenue Growth
- SRL N/A
- HLVX N/A
- 52 Week Low
- SRL $5.70
- HLVX $1.34
- 52 Week High
- SRL $9.99
- HLVX $2.15
- Technical
- Relative Strength Index (RSI)
- SRL 44.71
- HLVX 63.08
- Support Level
- SRL $5.84
- HLVX $1.98
- Resistance Level
- SRL $6.42
- HLVX $2.12
- Average True Range (ATR)
- SRL 0.24
- HLVX 0.08
- MACD
- SRL 0.06
- HLVX 0.01
- Stochastic Oscillator
- SRL 55.56
- HLVX 89.66
About SRL Scully Royalty Ltd.
Scully Royalty Ltd is a royalty-based company that maximizes earnings upon its iron ore royalty interest. The company's business segments include Royalty, which includes an interest in an iron ore mine; Industrial, which includes projects in resources and services; Merchant Banking, which comprises regulated merchant banking activities; and others. The majority of the revenue is generated from the Royalty segment. The company's geographical segments include Canada, Africa, America, Asia, and Europe, out of which Canada accounts for the majority of the revenue.
About HLVX HilleVax Inc.
HilleVax Inc is a clinical-stage biopharmaceutical company. The company is focused on developing and commercializing novel vaccines. The firm's initial program, HIL-214, is a virus-like particle (VLP) based vaccine candidate for the prevention of moderate-to-severe acute gastroenteritis (AGE) caused by norovirus infection.